Exhibit 99.1

HERBALIFE ANNOUNCES PROPOSED OFFERING OF $500 MILLION AGGREGATE PRINCIPAL
AMOUNT OF CONVERTIBLE SENIOR NOTES
LOS ANGELES (March 20, 2018)—Herbalife Ltd. (NYSE: HLF) (the “Company”) today announced that it intends, subject to market and other conditions, to offer $500 million aggregate principal amount of convertible senior notes due 2024 (the “Convertible Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
Final terms of the Convertible Notes, including the initial conversion price, interest rate and certain other terms of the Convertible Notes will be determined at the time of pricing. The Convertible Notes will be senior, unsecured obligations of the Company, and are expected to pay interest semiannually and upon conversion will be settled, at the Company’s election, in cash, the Company’s common shares, or a combination thereof, based on a conversion rate to be determined at the pricing of the Convertible Notes. The Convertible Notes will mature on March 15, 2024, unless redeemed, repurchased or converted in accordance with their terms prior to such date. Prior to December 15, 2023, the Convertible Notes will be convertible only upon the occurrence of certain events and during certain periods, and thereafter, at any time until the second scheduled trading day immediately preceding the maturity date.
The Company expects to use the net proceeds from the offering to repurchase a portion of the Company’s existing 2.00% convertible senior notes due 2019 (the “Existing Convertible Notes”) from a limited number of holders in privately negotiated transactions and for general corporate purposes.
The Company expects that, in connection with the intended repurchase of a portion of the Existing Convertible Notes, those holders of the Existing Convertible Notes that sell their Existing Convertible Notes to the Company may enter into or unwind various derivatives with respect to the Company’s common shares and/or purchase or sell the Company’s common shares in the market to hedge their exposure in connection with these transactions. In particular, the Company expects that many holders of the Existing Convertible Notes employ a convertible arbitrage strategy with respect to the Existing Convertible Notes and have a short position with respect to the Company’s common shares that they would close or reduce, through purchases of the Company’s common shares and/or the entry into various derivatives with respect to the Company’s common shares, in connection with the Company’s repurchase of their Existing Convertible Notes, including over a valuation period to be agreed separately with each such holder of Existing Convertible Notes that the Company expects to commence on the trading day immediately following the pricing of the Convertible Notes. This activity could result in an increase (or reduce the size of any decrease) in the market price of the Company’s common shares at that time.
In connection with the Company’s intended repurchase of Existing Convertible Notes, the Company expects to enter into agreements with the option counterparties to the capped call transactions entered into by the Company in connection with the Existing Convertible Notes, at one or more times concurrently with or following the pricing of the Convertible Notes, to terminate a portion of such existing capped call